Lifanta Ocular Surface Congregation 2025- Event

he Lifanta Ocular Surface Congregation 2025, hosted by Ajanta Pharma, brings together global expertise to discuss advancements in ocular surface management and dry eye disease.

This recorded session features Dr. Eric D. Donnenfeld, MD, a globally renowned ophthalmologist, sharing valuable clinical insights on lifitegrast therapy, its role in dry eye management, and real-world applications in modern ophthalmic practice.

Key highlights from the session include:
• Clinical efficacy and safety of lifitegrast
• Insights from landmark trials including OPUS-2, OPUS-3, and SONATA
• Real-world experience in dry eye disease management
• Reduction in artificial tear dependency
• Integration of lifitegrast in routine clinical practice
• Emerging perspectives on ocular surface health

This session is ideal for ophthalmologists, eye care professionals, and healthcare practitioners looking to stay updated with the latest advancements in ocular therapeutics.